Log in to save to my catalogue

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies...

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4829066

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins

About this item

Full title

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins

Publisher

Kidlington: Elsevier Ltd

Journal title

Vaccine, 2014-05, Vol.32 (22), p.2637-2644

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights • Nipah virus is an emerging zoonosis causing severe illness in humans. • ‘Emergency vaccines’ are needed for a practical outbreak response. • Live-attenuated single-dose VSV vectors expressing Nipah antigens are efficacious in hamsters. • Antibodies are the mechanism of protection conferred by the VSV vectors. • New VSV Nipah vectors ar...

Alternative Titles

Full title

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4829066

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4829066

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2014.02.087

How to access this item